Where is Glaukos Corp Headquarters?
The official headquarters of Glaukos is located at 1 Glaukos Way, Aliso Viejo, California, United States. This facility is situated within a region known for its concentration of medical technology and life sciences enterprises. The building serves as the primary base for the company's administrative and operational functions, providing the necessary infrastructure to support its ongoing research and development initiatives. The site is designed to accommodate the various departments required to oversee the manufacturing and distribution of ophthalmic products. As a fixed location, it provides a stable environment for the executive leadership team to coordinate the company's long-term business strategies and regulatory compliance efforts.
This location functions as the strategic core for the company's global operations, housing key departments such as corporate management, legal, and commercial strategy. By centralizing these essential functions in Aliso Viejo, the company ensures efficient oversight of its product pipeline, including the iStent and iDose TR platforms. The facility acts as the command center for managing relationships with international distributors and the direct sales organization that serves the United States market. Furthermore, the site supports the integration of clinical research data and commercial activities, which are vital for maintaining the company's position in the ophthalmic sector. This main facility remains integral to the execution of the company's mission to provide innovative treatments to patients worldwide.
Other Glaukos Corp Office Locations
Main Headquarters
Office Locations
Aliso Viejo, CA
Richmond Hill
Waltham, MA
Runcorn
Falls Church, VA
Barcelona
These locations enable Glaukos Corp to tap into local talent markets, improve service delivery, and maintain a strong presence across continents.
More Headquarters in California
Frequently Asked Questions Regarding Glaukos Corp Headquarters and Office Locations
Sign Up for Free to explore more.